3 research outputs found
Additional file 1: Table S1. of A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials
Project identification numbers of included articles. Table listing all trials in cohort. (DOCX 48Â kb
Five Stages of the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) trial
IDMC = Independent Data Monitoring Committee; FFS = failure-free survival; HR = hazard ratio, where 0 ≤ d ≤ c ≤ b ≤ a ≤ 5.<p><b>Copyright information:</b></p><p>Taken from "Speeding up the Evaluation of New Agents in Cancer"</p><p></p><p>JNCI Journal of the National Cancer Institute 2008;100(17):1204-1214.</p><p>Published online 3 Sep 2008</p><p>PMCID:PMC2528020.</p><p></p
Stopping guidelines on the hazard ratio scale for the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) trial
CI = confidence interval; HR = hazard ratio; Stop = stopping of accrual (rather than termination of follow up).<p><b>Copyright information:</b></p><p>Taken from "Speeding up the Evaluation of New Agents in Cancer"</p><p></p><p>JNCI Journal of the National Cancer Institute 2008;100(17):1204-1214.</p><p>Published online 3 Sep 2008</p><p>PMCID:PMC2528020.</p><p></p